CCL3 and neoplasm: To further confirm the influence of PLS-123 towards BCR signaling pathway, CCL3 and CCL4 chemokine secretions from tumor cells after Btk inhibitor treatment, which is highly regulated and correlated with the signal activation of the BCR [15, 16], were measured via real-time PCR and ELISA.